BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6973775)

  • 1. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cisternography via computerised tomography: technique and pathophysiology as causes of the side effects (author's transl)].
    Hammer B
    Rontgenblatter; 1981 May; 34(5):185-9. PubMed ID: 7017889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.
    Hammer B; Lackner W
    Neuroradiology; 1980 Apr; 19(3):119-21. PubMed ID: 6991972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
    Moschini L; Manara O; Bonaldi G; Cassinari V; Quilici N; Belloni G
    AJNR Am J Neuroradiol; 1983; 4(3):848-50. PubMed ID: 6410870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide.
    Skalpe IO
    Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C; Malaguti C; Manfredini M; Tampieri D
    AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of iopamidol with metrizamide in sub-occipital ventriculography/cisternography.
    Macpherson P; Teasdale E
    Br J Radiol; 1982 Jul; 55(655):540-1. PubMed ID: 6983902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study].
    Bockenheimer S; Eichenlaub H
    Rontgenpraxis; 1986 May; 39(5):171-4. PubMed ID: 3523789
    [No Abstract]   [Full Text] [Related]  

  • 11. [The CT-scan and hypocycloidal cysternography with water soluble non ionic contrast media (metrizamide and iopamidol) in sellar and parasellar lesions (author's transl)].
    Fiore D; Pardatscher K; Iavicoli R; Iraci G; Zuccarello M; Fiore D
    Radiol Med; 1981 Mar; 67(3):119-26. PubMed ID: 7268082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
    Vézina JL; Fox AJ
    J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of radiographic quality and adverse reactions in myelography with iopamidol and metrizamide.
    Bannon KR; Braun IF; Pinto RS; Manuell M; Sudilovsky A; Kricheff II
    AJNR Am J Neuroradiol; 1983; 4(3):312-3. PubMed ID: 6410730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the acute cardiovascular side effects of iopamidol, metrizamide and amidotrizoate after intracoronary and left ventricular injections].
    Schräder R; Wolpers HG; Hoeft A; Korb H; Hellige G
    Radiologe; 1984 May; 24(5):240-6. PubMed ID: 6463236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of metrizamide and iopamidol for myelography.
    Turski PA; Sackett JF; Gentry LR; Strother CM; Matozzi F
    AJNR Am J Neuroradiol; 1983; 4(3):309-11. PubMed ID: 6410729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelography with lopamidol.
    Lamb JT; Holland IM
    AJNR Am J Neuroradiol; 1983; 4(3):851-3. PubMed ID: 6410871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model.
    Haughton VM; Ho KC
    Invest Radiol; 1980; 15(6 Suppl):S267. PubMed ID: 7203934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelography with B 15000, a new nonionic water-soluble contrast medium. Technical aspects and preliminary clinical experiences (author's transl)].
    Smaltino F; Ciccarelli R; Cirillo S; D'Auria T; Gambardella A; La Tessa G; Meoli S; Rotondo A; Santoro S
    Radiol Med; 1980 Apr; 66(4):203-10. PubMed ID: 7005985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The symptomatic complications of iopamidol (Niopam) and metrizamide (Amipaque) following lumbar radiculography.
    Stoddart PG; Watt I
    Br J Radiol; 1984 Apr; 57(676):349-50. PubMed ID: 6704672
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual evoked response changes following intrathecal injection of water-soluble contrast media: a possible method of assessing neurotoxicity and a comparison of metrizamide and iopamidol.
    Broadbridge AT; Bayliss SG; Firth R; Farrell G
    Clin Radiol; 1984 Sep; 35(5):371-3. PubMed ID: 6547888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.